2020年4月17日Published by webmaster@fronteo.com on 2020年4月17日Categories 2020 global NEWS Press ReleaseFRONTEO begins drug repositioning research for novel coronavirus (COVID-19) using AI TOKYO, April 17, 2020 — FRONTEO, Inc. (“FRONTEO”) (TSE: 2158), a leading […]
2020年3月25日Published by webmaster@fronteo.com on 2020年3月25日Categories 2020 global NEWS Press ReleaseFRONTEO signs license agreement with Takeda Pharmaceutical Company for drug discovery support AI system to solve issues in drug discovery TOKYO, March 25, 2020 — FRONTEO, Inc. (“FRONTEO”) (TSE: 2158), a leadin […]
2020年3月2日Published by webmaster@fronteo.com on 2020年3月2日Categories 2020 global NEWS Press ReleaseKyowa Pharmaceutical Industry and FRONTEO sign basic agreement on business alliance for dementia diagnosis support system using AI TOKYO, March 2, 2020 — FRONTEO, Inc. (“FRONTEO”) (TSE: 2158), a leading […]
2020年1月31日Published by webmaster@fronteo.com on 2020年1月31日Categories 2020 global NEWS Press ReleaseFRONTEO Announces Plan to Delist American Depositary Receipts from NASDAQ Global Market and Deregister with U.S. Securities and Exchange CommissionFRONTEO, Inc., Tokyo– FRONTEO, Inc. (NASDAQ: FTEO) (TSE: 2158), a leading […]
2019年12月24日Published by webmaster@fronteo.com on 2019年12月24日Categories 2019 global NEWS Press ReleaseFRONTEO to Announce the Results of Survey in “LegalTech AI White Paper”TOKYO, December 24, 2019 – FRONTEO, Inc. (“FRONTEO”) (NASDAQ: FTEO) (TSE: […]